ストックスクリーナーアプリを入手
56.76
0.18%
-0.10
アフターアワーズ：
56.90
0.14
+0.25%
前日終値:
$56.86
開ける：
$57.15
24時間の取引高:
1.98M
Relative Volume:
1.05
時価総額：
$5.45B
収益：
$3.51M
当期純損益:
$-581.60M
株価収益率:
-8.7129
EPS:
-6.5145
ネットキャッシュフロー:
$-345.93M
1週間 パフォーマンス:
+9.66%
1か月 パフォーマンス:
+16.43%
6か月 パフォーマンス:
-20.97%
1年 パフォーマンス:
+45.73%
1日の値動き範囲:
$55.76
$59.39
1週間の範囲:
$49.50
$59.39
52週間の値動き範囲:
$33.03
$78.48
Crispr Therapeutics Ag Stock (CRSP) Company Profile
Compare CRSP vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRSP
Crispr Therapeutics Ag
|
56.76 | 5.46B | 3.51M | -581.60M | -345.93M | -6.5145 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Crispr Therapeutics Ag Stock (CRSP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-18 | 開始されました | JP Morgan | Overweight |
| 2025-02-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-02-12 | アップグレード | TD Cowen | Sell → Hold |
| 2025-02-03 | 開始されました | H.C. Wainwright | Buy |
| 2024-08-06 | 繰り返されました | Needham | Buy |
| 2024-08-02 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-28 | 再開されました | Guggenheim | Neutral |
| 2024-02-15 | 開始されました | Wolfe Research | Peer Perform |
| 2023-12-11 | ダウングレード | TD Cowen | Market Perform → Underperform |
| 2023-10-17 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-09-27 | 開始されました | Mizuho | Buy |
| 2023-08-17 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-30 | 開始されました | William Blair | Outperform |
| 2023-04-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-03-21 | 開始されました | Bernstein | Mkt Perform |
| 2023-03-17 | 開始されました | Bryan Garnier | Buy |
| 2023-03-07 | 開始されました | Robert W. Baird | Neutral |
| 2022-10-11 | 開始されました | Morgan Stanley | Underweight |
| 2022-08-09 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-06-23 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-04-28 | 開始されました | Credit Suisse | Neutral |
| 2021-12-07 | 開始されました | Cowen | Market Perform |
| 2021-10-19 | 開始されました | SVB Leerink | Outperform |
| 2021-06-14 | アップグレード | Citigroup | Sell → Neutral |
| 2021-04-21 | アップグレード | Jefferies | Hold → Buy |
| 2021-03-04 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-12-10 | 繰り返されました | Chardan Capital Markets | Buy |
| 2020-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2020-12-10 | 繰り返されました | Needham | Buy |
| 2020-12-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2020-10-05 | 開始されました | BofA Securities | Buy |
| 2020-07-28 | 繰り返されました | Needham | Buy |
| 2020-07-14 | 開始されました | SunTrust | Buy |
| 2020-06-15 | 繰り返されました | Canaccord Genuity | Buy |
| 2020-03-05 | 開始されました | Stifel | Hold |
| 2020-02-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-11-19 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2019-11-12 | アップグレード | Oppenheimer | Perform → Outperform |
| 2019-08-01 | 開始されました | Jefferies | Buy |
| 2019-07-26 | 開始されました | Canaccord Genuity | Buy |
| 2019-06-10 | 開始されました | ROTH Capital | Buy |
| 2019-04-12 | 開始されました | Evercore ISI | Outperform |
| 2019-03-14 | 開始されました | William Blair | Mkt Perform |
| 2019-01-28 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-22 | ダウングレード | Citigroup | Neutral → Sell |
すべてを表示
Crispr Therapeutics Ag (CRSP) 最新ニュース
Sumitomo Mitsui Trust Group Inc. Sells 205,564 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics Touts “Second Phase” After Casgevy, Eyes 6 Data Readouts in 6–12 Months - MarketBeat
CRISPR Therapeutics Improves Cash Position Amid Pipeline Expansion - Intellectia AI
2 Billion Reasons to Love CRISPR Therapeutics Right Now - The Motley Fool
Momentum Shift: Is CRISPR Therapeutics AG a strong growth stock2026 Update & Safe Capital Investment Plans - baoquankhu1.vn
Published on: 2026-04-13 17:48:33 - baoquankhu1.vn
Aug Highlights: What is the long term forecast for CRISPR Therapeutics AG stockMarket Sentiment Review & Entry Point Strategy Guides - baoquankhu1.vn
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know - MSN
Is CRISPR Therapeutics (CRSP) Pricing In Too Much Hope After Recent Share Price Recovery - Yahoo Finance
CRISPR’s One-Time ANGPTL3 Edit for Lipids Might Change The Case For Investing In CRISPR Therapeutics (CRSP) - Sahm
Bank Watch: What is the long term forecast for CRISPR Therapeutics AG stockWeekly Stock Report & Daily Market Momentum Tracking - baoquankhu1.vn
Is CRISPR Therapeutics AG a strong growth stock2026 Technical Patterns & Expert Approved Trade Ideas - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
CRSP Stock Price, Quote & Chart | CRISPR THERAPEUTICS AG (NASDAQ:CRSP) - ChartMill
Why is CRISPR Therapeutics AG stock going down2026 Technical Patterns & Daily Growth Stock Investment Tips - baoquankhu1.vn
Is CRISPR Therapeutics (CRSP) Pricing Reflect Its Sharp Five‑Year Share Price Pullback - simplywall.st
Bank of America Securities Remains a Buy on Crispr Therapeutics AG (CRSP) - The Globe and Mail
Price-Driven Insight from (CRSP) for Rule-Based Strategy - Stock Traders Daily
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History - Yahoo! Finance Canada
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Sell Signal: Should I set a stop loss on CRISPR Therapeutics AG2026 Volume Leaders & Proven Capital Preservation Methods - baoquankhu1.vn
CRISPR Therapeutics: Potential Breakthroughs in Gene Editing - Intellectia AI
Can CRISPR Therapeutics AG stock outperform in a bear marketStock Surge & Long-Term Capital Growth Ideas - baoquankhu1.vn
Del-Sette Capital Management, LLC's CRISPR Therapeutics AG(CRSP) Holding History - GuruFocus
CRISPR Therapeutics AG (CRSP) stock price, news, quote and history - sg.finance.yahoo.com
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
Genome Editing Market Is Going to Boom |• CRISPR Therapeutics • Editas Medicine - openPR.com
CRISPR Therapeutics AG (CRSP) latest stock news and headlines - Yahoo Finance Australia
Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Revenue And Cash Position Support Its Growth Transition - Sahm
LTS:0VRQ PB Ratio: 2.47 — 22% Below Median - GuruFocus
CRISPR Therapeutics Hits Day Low of $50.66 Amid Price Pressure - Markets Mojo
Did CRISPR’s Cash Raise, Casgevy Launch and Insider Buying Just Shift CRISPR Therapeutics' (CRSP) Investment Narrative? - Sahm
CRISPR Therapeutics AG (CRSP) rises higher than market: Key facts - MSN
Crispr Therapeutics Ag (CRSP) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):